Please note that masks are still required in all Blue Ridge Cancer Care offices regardless of vaccination status.
Learn more about this and other current Covid-19 policies.

Research Institute

Phase 3 Study of Amivantamab in Lung Cancer

A Randomized, Open-label Phase 3 Study of Combination Amivantamab and Carboplatin-Pemetrexed Therapy, Compared with Carboplatin-Pemetrexed, in Patients with EGFR Exon 20ins Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Disease Types: Lung

Available at: AlleghanyBlacksburgRoanokeSalemWytheville

For more information:

https://clinicaltrials.gov/ct2/show/NCT04538664?term=A+Randomized%2C+Open-label+Phase+3+Study+of+Combination+Amivantamab+and+Carboplatin-Pemetrexed+Therapy%2C+Compared+with+Carboplatin-Pemetrexed%2C+in+Patients+with+EGFR+Exon+20ins+Mutated+Locally+Advanced+or+Metastatic+Non-Small+Cell+Lung+Cancer&draw=2&rank=1